Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

HMPL-306

2 clinical trials

1 indication

Indication
IDH Mutation
Clinical trial
A Multicenter, Open-Label, Phase I Study Evaluating the Safety and Tolerability of HMPL-306 in Subjects With Advanced or Metastatic Solid Tumors With IDH Mutations
Status: Active (not recruiting), Estimated PCD: 2024-03-30
Clinical trial
A Phase 1, Open-Label, Multicenter Study of HMPL-306 in Advanced Hematological Malignancies With Isocitrate Dehydrogenase (IDH) Mutations
Status: Recruiting, Estimated PCD: 2024-09-30